Aptorum Group Ltd

Contributing Author

Recent Articles by Aptorum Group Ltd

Mar-10	Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania APM GlobeNewswire
Mar-06	Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency APM GlobeNewswire
Feb-02	Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB's Automated APOE Testing Platform for Alzheimer's Disease APM -10.22% GlobeNewswire
Nov-19	DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer's Disease (CTAD) 2025 Conference APM GlobeNewswire
Oct-10	Aptorum Group Limited Announces Up To $6 Million Registered Direct Offering APM -29.96% GlobeNewswire
Oct-09	As part of the planned merger with DiamiR Biosciences, Aptorum Group will expand its board and management team with seasoned executives APM GlobeNewswire
Sep-05	Aptorum Group and DiamiR Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference APM GlobeNewswire
Aug-21	DiamiR Biosciences and Aptorum Group Announce New York State Approval for DiamiR's APOE Genotyping Test APM +234.65% GlobeNewswire
Aug-04	Aptorum Group Limited Regains Compliance with NASDAQ's Minimum Bid Price Requirement APM GlobeNewswire
Jul-16	Aptorum Group Limited and DiamiR Biosciences Enter into Definitive Merger Agreement APM +100.04% GlobeNewswire